45.43
2.93 (6.89%)
| Previous Close | 42.50 |
| Open | 42.50 |
| Volume | 64,120 |
| Avg. Volume (3M) | 111,736 |
| Market Cap | 746,705,664 |
| Price / Sales | 0.810 |
| Price / Book | 43.86 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2025 - 4 Aug 2025 |
| Profit Margin | -126.96% |
| Operating Margin (TTM) | 4.21% |
| Diluted EPS (TTM) | -72.90 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Total Debt/Equity (MRQ) | 31,271.65% |
| Current Ratio (MRQ) | 1.02 |
| Operating Cash Flow (TTM) | 27.84 M |
| Levered Free Cash Flow (TTM) | 140.38 M |
| Return on Assets (TTM) | 0.83% |
| Return on Equity (TTM) | -198.69% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | Claritev Corporation | Bearish | - |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 4.0 |
| Average | 0.13 |
|
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 7.81% |
| % Held by Institutions | 82.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| H&F Corporate Investors Viii, Ltd. | 31 Mar 2025 | 5,387,858 |
| Cpv Partners, Llc | 31 Mar 2025 | 495,258 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 86.00 (Piper Sandler, 89.30%) | Buy |
| Median | 80.00 (76.10%) | |
| Low | 74.00 (Citigroup, 62.89%) | Buy |
| Average | 80.00 (76.10%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 68.85 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 22 Oct 2025 | 74.00 (62.89%) | Buy | 66.08 |
| 21 Oct 2025 | 55.00 (21.07%) | Buy | 66.00 | |
| Piper Sandler | 15 Aug 2025 | 86.00 (89.30%) | Buy | 71.61 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 27 Oct 2025 | Announcement | Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region |
| 16 Oct 2025 | Announcement | Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call |
| 08 Oct 2025 | Announcement | Claritev and iO Health Forge Strategic Relationship to Bring AI-Powered Revenue Cycle Management Optimization to the MENA Region |
| 17 Sep 2025 | Announcement | Claritev Expands Golf Sponsorships, Re-Signs Neal Shipley and Adds Bud Cauley, Ryan Fox and Darren Clarke |
| 11 Sep 2025 | Announcement | Claritev Earns 2025 Great Place To Work® Certification™ and Makes Fortune’s Best Workplaces in Health Care™ List Again |
| 27 Aug 2025 | Announcement | Claritev Corporation Announces Participation at Upcoming Conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |